Frontier Capital (508980)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹26.1 |
| Market Cap | ₹43.75 Cr |
| P/E Ratio | 59.21 |
| ROCE | 11.31% |
| ROE | 9.37% |
| Dividend Yield | 0% |
| Profit Growth | -92.31% |
| Debt/Equity | — |
| Sales Growth | -6.67% |
| 52-Week Range | ₹5.3 — ₹26.1 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹1.44 |
Strengths
- Trailing ROE of 9.37% and ROCE of 11.31% show some capital efficiency despite the sharp profit collapse.
- Sales decline of -6.67% is much milder than the -92.31% profit decline, suggesting revenue is not in freefall.
- Positive book value of ₹1.44 per share indicates the company still has equity cushion, though small.
- Small market cap of ₹44 crore could allow a meaningful percentage rerating if operational recovery begins.
Concerns
- Valuation is extreme: P/E of 59.21 and P/B of 18.13 leave no room for error.
- Profit growth collapsed 92.31%, and the latest quarter reported zero sales and zero net profit.
- Piotroski F-Score of 3/9 signals weak fundamental health across profitability, leverage, and efficiency.
- Debt/Equity, promoter holding, and dividend data are missing or nil, reducing transparency and investor return.
AI Analysis
Let me start with Benjamin Graham's first rule: an investment is a proposition that gives you a margin of safety. At ₹26.10, Frontier Capital has a market cap of just ₹44 crore, but I am being asked to pay 59 times trailing earnings and over 18 times book value. For that price, I want a growing, predictable stream of profits. Instead, I see sales down 6.67% and profit down a devastating 92.31%. The latest quarter shows zero revenue and zero net profit. That is not a business; that is a shell waiting for a story. The ROE of 9.37% and ROCE of 11.31% are modest at best, and the Piotroski F-Score of 3/9 confirms weak financial health. There is no dividend yield, so the minority shareholder receives no return while waiting for a recovery that may never come. Debt/equity is not disclosed, promoter holding is not available, and with book value of only ₹1.44 per share, the stock trades at a huge premium to tangible worth. Perhaps the market is pricing in a turnaround; the share has climbed from ₹5.30 to its 52-week high of ₹26.10. But price action is not evidence of value. In fact, the latest quarter's zero numbers suggest the turnaround is not visible yet. I would need several quarters of genuine revenue, real profit, and a sane price-to-book relationship before owning this. Today, the margin of safety is on the seller's side, not mine.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer